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Monoclonal antibodies to Neurospora crassa cyclic nucleotide phosphodiesterase (PDE I) were selected by their capacity 
to inhibit he enzyme activity. The monoclonal immunoglobulin, coupled to Sepharose 4B, was used for the affinity purifi- 
cation of PDE I activity. After SDS-polyacrylamide gelelectrophoresis the affinity purified PDE I fractions howed a
single polypeptide band of about 41 kDa. This band reacted in Western blots with the above mentioned monoclonal 
immunoglobulin. 
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1. INTRODUCTION 
Some properties of Neurospora crassa cyclic 
nucleotide phosphodiesterase activities (EC 
3.1.4.17) have been described in this laboratory [1]. 
Two different enzyme activities could be resolved 
by DEAE-cellulose column chromatography from 
soluble mycelial extracts. One of them (PDE I) is 
active on both cyclic AMP and cyclic GMP, 
whereas the other (PDE II) is more active with 
cyclic GMP. These two enzyme activities exist in 
different aggregation forms. 
Calmodulin is a known activator of cyclic 
nucleotide phosphodiesterase from different 
sources, including Neurospora [2,3]. In 
Neurospora, the modulator seems to play a dual 
Correspondence address: M.T. T611ez-Ifi6n, INGEBI, Obligado 
2490, 1428 Buenos Aires, Argentina 
* Career member of the Consejo Nacional de Investigaciones 
Cientificas y T6cnicas 
+ Fellow of the latter Institution 
role in the control of cyclic AMP metabolism since 
in the presence of Ca 2+, calmodulin activates both 
adenylate cyclase and PDE I [3,4]. These activa- 
tions were blocked by EGTA and some neuroleptic 
drugs such as chlorpromazine and flufenazine. 
Moreover, these drugs inhibited the elongation of 
N. crassa wild-type aerial hyphae indicating that 
the CaZ+-calmodulin complex is involved in the 
control of cyclic nucleotide levels in Neurospora 
[3]. 
The present paper eports a further purification 
and characterization of the N. crassa cyclic 
nucleotide phosphodiesterase, PDE I, using 
monoclonal ntibodies with the capacity to inhibit 
this enzyme's activity. 
2. EXPERIMENTAL 
2.1. Materials 
The sources of materials used in this work have been given in 
previous papers [1,3,5,6]. Immunoglobulins were obtained 
from Cappel Laboratories, West Chester, PA, USA or from 
Zymed Laboratories, San Francisco, CA, USA. Cyanogen 
bromide activated Sepharose 4B was purchased from Phar- 
macia Fine Chemicals, Uppsala, Sweden. 
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2.2. Phosphodiesterase purification 
Cyclic nucleotide phosphodiesterase PDE I was purified by 
two sequential DEAE-cellulose column chromatographies as 
previously described [1,3]. Purified PDE I fractions had a 
specific activity of about 100 pmol/min per mg protein. 
2.3. Preparation of  monoclonal antibodies 
The procedure followed has been described elsewhere [5,6]. 
Clones were selected for the capacity of culture media to inhibit 
cyclic AMP phosphodiesterase activity. Three hybridoma clones 
out of 200, showing the highest capacity to inhibit enzyme ac- 
tivity, designated 17, 32, and 37, were subcloned and used for 
further experiments. 
2.4. Purification and characterization f monoclonal immuno- 
globulins 
Purification of immunoglobulins from culture media was per- 
formed as described by Fundenberg [7] with some modifica- 
tions. The hybridoma media were precipitated with solid am- 
monium sulfate to 50% saturation and the sedimented material 
resuspended and dialyzed against sodium phosphate buffer, pH 
8.0. The resuspended fractions (3.6 ml, 2.9 mg/ml ofprotein for 
clone 17 and 3 ml, 2.8 mg/ml of protein for clone 32) were load- 
ed onto DEAE-cellulose columns (1 x 6 cm) equilibrated with 
the same buffer solution, washed with two bed volumes of this 
buffer solution, and stepwise luted with two bed volumes of 35, 
50, 100,200, and 300 mM sodium phosphate buffer, pH 8.0. All 
fractions eluted from the DEAE-cellulose columns were assayed 
for their capacity to inhibit Neurospora phosphodiesterase c- 
tivity. The protein peak in the flow-through fraction of clone 32 
and the fractions eluting at 200 mM sodium phosphate buffer of 
clones 17 and 37 had the highest inhibitory capacity. These 
selected fractions were concentrated against solid sucrose and 
used as the source of monoclonal IgG and IgMs, respectively. 
Characterization f monoclonal immunoglobulins was per- 
formed by immunoelectrophoresis as described by Williams [8] 
and by enzyme-linked immunoassays (ELISA) using different 
goat anti-mouse immunoglobulins coupled to peroxidase (Zym- 
ed Laboratories), according to the procedure suggested by the 
manufacturer. ELISA tests of the culture media were performed 
on nitrocellulose membranes u ing as a second layer one of the 
following immunoglobulins conjugated to peroxidase: rabbit 
anti-mouse IgD' (/Lchain specific), rabbit anti-mouse lgM (u- 
chain specific) or goat anti-mouse IgG (heavy and light chain 
specific). Controls were performed using mouse lgM (positive 
control) or myeloma cell conditioned medium (negative con- 
trol). Assays were performed four, five or six weeks after 
plating the hybrids. 
2.5. Immunoaffinity purification of  PDE I 
Purified IgM from clone 17 was covalently coupled to 
cyanogen bromide-activated Sepharose 4B according to the 
manufacturer's protocol and used as an affinity support for 
PDE 1 purification. The column (0.6 × 5.5 cm; about 1.35 mg 
of bound protein/ml) was equilibrated with 25 mM Tris-HCl 
buffer, pH 7.4, containing 0.1 M NaC1. A PDE I preparation (2
ml, 1.9 mg/ml protein) was loaded onto the column and the 
sample was allowed to equilibrate for 60 rain to promote the 
antigen-antibody interaction. The column was washed with the 
same buffer until no absorbance at 280 nm was detected. Bound 
antigens were eluted with three column volumes of distilled 
water [9] followed by two column volumes of 0.5 M NaCI. This 
chromatography was repeated three times using the flow- 
through fraction of the previous column chromatography, as 
enzyme source for the second one and in the same form for the 
third column. Fractions with phosphodiesterase ctivity were 
pooled, lyophilized and subjected to polyacrylamide g l elec- 
trophoresis under denaturing conditions. 
2.6. Western blot 
Partially purified PDE I (DEAE fraction, 100ag protein) and 
protein markers (Pharmacia) were electrophoresed on 0.1% 
SDS/12.5%0 polyacrylamide slab gels under denaturing condi- 
tions [10]. Transference to nitrocellulose membranes was per- 
formed according to the procedure of Yowbin et al. [11]. 
Modifications of this method as well as blockage of the 
nitrocellulose trips and antibody reactions were as described by 
Torruella et al. [6]. Proteins were stained with India ink [12]. 
2.7. Phospbodiesterase assay 
Enzyme activity was assayed essentially by the method of 
Thompson and Appleman [13] with the modifications indicated 
by Londesborough [14] and T611ez-lfi6n et al. [1]. Reaction mix- 
tures contained 40 mM Tris-HCI buffer, pH 7.5, 5 mM MgCI2 
and 1 /zM cyclic [3H]AMP (specific radioactivity 600 
cpm/pmol). When indicated mixtures were supplemented with 
25/~M CaCI2 and 2,'90 ng of N. cras~a calmodulin. Total volume 
was 0.1 ml. Assay conditions were selected so that cyclic AMP 
hydrolysis had a linear dependence on incubation time and en- 
zyme concentration. 
To test the inhibitory capacity of the secreting clones, a PDE 
I preparation was preincubated with variable concentrations of 
each culture medium or purified IgG or IgM at 4°C for 60, 120 
and 180 rain. The mixtures were then assayed for 
phosphodiesterase ctivity as indicated. 
3. RESULTS AND DISCUSSION 
N.  crassa cyclic AMP phosphod ies terase  PDE I 
act iv i ty was pur i f ied  by DEAE-ce l lu lose  co lumn 
chromatography  o f  so luble mycel ia l  extracts.  This 
PDE I act iv ity p reparat ion ,  ful ly dependent  on 
Ca  2+ and  ca lmodu l in ,  was used to generate  mono-  
c lona l  ant ibod ies .  
Three  stable l ines, des ignated  c lones 17, 32, and 
37, were  selected for  their  capaci ty  to inhibit  en- 
zyme activity.  Monoc lona l  immunog lobu l ins  f rom 
these c lones were pur i f ied  and  character i zed  in 
te rms o f  cha in  s t ructure  and  their  inh ib i tory  
capac i ty .  As shown in table  1, the highest  inhibi -  
t ion  o f  PDE I act iv ity cor responds  to c lone 17 and 
was assoc ia ted  to an immunog lobu l in  o f  the IgM 
type.  
The  ef fect  o f  c lone 17 monoc lona l  immunog lo -  
bul in  was tested as shown in fig. 1. Inh ib i t ion  by 
the pur i f ied  IgM was propor t iona l  to its concent ra -  
t ion,  reach ing a max imum value o f  about  60°70 o f  
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Table 1 
Characterization of monoclonal immunoglobulins with the 
capacity to inhibit Neuro6pora PDE 1 
Medium PDE I inhibition (%) lmmunoglobulin chains 
Heavy Light 
2b /z 
- + + - 
+ - _ + 
- + + - 
Control 2 
Clone 17 63 
Clone 32 45 
Clone 37 37 
total enzyme activity at the highest amount of im- 
munoglobulin tested. In contrast, purified IgA or 
IgG from clone 17 was not inhibitory. When the 
IgM fraction was pretreated with anti-mouse IgM 
no inhibition was detected, confirming the specifi- 
city of this fraction. In addition, protein fractions 
from a control medium had no inhibitory effect 
(not shown). 
The purified monoclonal IgM from clone 17, 
covalently coupled to Sepharose 4B, was used for 
the immunoaffinity purification of PDE I. After 
absorption, the enzyme activity was eluted with 
water according to the procedure of Garberi et al. 
[9], and thereafter with 0.5 M NaC1 (fig. 2). The 
two phosphodiesterase activity peaks thus eluted 
were fully activated by Ca z+ and calmodulin (not 
shown). Both fractions analyzed on SDS-PAGE 
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Fig.2. Immunoaff inity chromatography of PDE I activity. 
(~- - -e )  PDE activity; (A A) protein. Conditions were as 
indicated in section 2. 
showed only one stained polypeptide band of 
about 41 kDa (fig. 3). 
Moreover, a PDE I DEAE preparation transfer- 
red to nitrocellulose membranes was incubated 
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Fig.1. Effect of  monoclonal immunoglobulin to Neurospora 
PDE I activity on cyclic AMP phosphodiesterase activity. 
Samples of a PDE I DEAE preparation (25 /zg protein) were 
preincubated for 180 rain at 22°C with variable amounts of the 
purified monoclonal IgM (O-- -~),  IgA (o- - -Q) ,  IgG (z~ zx) 
from clone 17. Other conditions were given in section 2. 
30 
20.1 
14.4 . . . .  
Fig.3. SDS-PAGE of a PDE I DEAE preparation (lane a) and 
both peaks (lanes b and c) purified by immunoaff inity 
chromatography described in fig. 1. Molecular mass markers 
are indicated (phosphorylase b, bovine serum albumin, 
ovalbumin, carbonic anhydrase, trypsin inhibitor and a- 
lactalbumin). Conditions were as indicated in section 2. 
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Fig.4. A PDE 1 DEAE preparation (100 /zg protein) was 
electrophoresed on SDS-PAGE and transferred to 
nitrocellulose. The strips were incubated with IgM fraction of 
clone 17 (lane b) or with a monoclonal antibody against surface 
glycoproteins of T. cruzi (lane c). (Lane a) Proteins tained with 
India ink. Molecular mass markers are indicated. Conditions 
were described in section 2. 
with the monoclonal IgM secreted by clone 17. The 
antibody recognized a 41 kDa band which is 
equivalent o the one obtained by the immunoaf- 
finity chromatography and two lesser bands which 
are probably proteolytic fragments of the enzyme. 
A monoclonal antibody against surface glycopro- 
teins of T. cruzi, used as control, did not react with 
the enzyme preparation (fig. 4). 
Previous work from this laboratory showed that 
PDE I activity in soluble mycelial extracts presents 
three aggregation forms, tentatively defined as 
monomeric, dimeric and tetrameric, having mole- 
cular masses of about 57, 126 and 225 kDa [1]. The 
evidence reported here indicates that the 
monomeric form may be the result of the associa- 
tion of the 41 kDa polypeptide with a calmodulin 
molecule. The modulator, as reported by this and 
other laboratories [3,2], is a polypeptide with a 
molecular mass of about 16 kDa. 
REFERENCES 
[11 T611ez-Ifi6n, M.T., Glikin, G.C. and Torres, H.N. (1982) 
Biochem, J. 203, 6ll-616. 
[2] Ortega-P6rez, R., Van Tuinen, D., Marm6, D., Cox, A.J. 
and Turian, G. (1981) FEBS Lett. 133, 205-209. 
[3] Tdllez-Ifi6n, M.T., Ulloa, R.M., Glikin, G.C. and Torres, 
H.N. (1985) Biochem. J. 232, 425-430. 
[4] Reig, J.A., Tdllez-lfi6n, M.T., Flawi& M.M. and Torres, 
H.N. (1984) Biochem. J. 221, 541-543. 
[5] Molina y Vedia, L., Torruella, M., Flawi~i, M.M. and 
Torres, H.N. (1983) Biochem. Biophys. Res. Commun. 
113, 778-783. 
[6] Torruella, M., Flawi~, M.M., Eisenschlos, C., Molina y 
Vedia, L., Rubinstein, C.P. and Torres, H.N. (1986) 
Biochem. J. 234, 145-150. 
[7] Fundenberg, H.H. (1967) in: Methods in Immunology and 
lmmunochemistry (Williams, C.A. and Chase, M.W. eds) 
vol. I, pp. 306-335, Academic Press, New York. 
[8] Williams, C.A. (1971) in: Methods in Immunology and 
lmmunochemistry (Williams, C.A. and Chase, M.W. eds) 
vol. I11, pp. 234-273, Academic Press, New York. 
[91 Garberi, J.C., Macario, A.J.L. and Conway de Macario, 
E. (1985) J. Bacteriol. 164, 1-6. 
[10] Laemmli, U.K. (1970) Nature 227, 680-685. 
[11] Towbin, H., Staphelin, T. and Gordon, J. (1979) Proc. 
Natl. Acad. Sci. USA 76, 4350-4354. 
[12] Hancock, K., and Tsang, V. Anal. Biochem. 133, 
157-162. 
[13] Thompson, W.J. and Appleman, M.M. (1971) 
Biochemistry 10, 311-316. 
[14] Londesborough, J. (1976) Anal. Biochem. 71, 623-628. 
222 
